West Pharmaceutical Services Inc.
Income Statement
| Line Item | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|
| Revenue | $1.15B | $1.05B | $1.12B | $1.06B | $936.4M |
| Service | $381.1M | $350.5M | $358.5M | $314.9M | $290.7M |
| Product | $770.8M | $701.3M | $765.1M | $742.6M | $645.7M |
| Cost of Revenue | $786.6M | $752.1M | $748.5M | — | — |
| Gross Profit | $318.1M | $303.6M | $302.6M | — | — |
| Gross Margin | 27.6% | 28.9% | 26.9% | — | — |
| Operating Expenses | |||||
| Research & Development | $23.9M | $19.9M | $18.7M | — | — |
| SG&A Expense | $187.7M | $177.7M | $159.3M | — | — |
| Operating Income | $90.7M | $97.5M | $124.1M | — | — |
| Operating Margin | 7.9% | 9.3% | 11.0% | — | — |
| Interest Expense | $16.8M | $15.2M | $16.0M | — | — |
| Pretax Income | $74.5M | $83.1M | $109.5M | — | — |
| Income Tax Expense | $13.6M | $13.5M | $23.7M | — | — |
| Net Income | $65.3M | $72.6M | $86.0M | — | — |
| Net Margin | 5.7% | 6.9% | 7.7% | — | — |
| EPS (Basic) | $0.98 | $1.11 | $1.33 | — | — |
| EPS (Diluted) | $0.95 | $1.06 | $1.25 | — | — |
| Shares Outstanding (Basic) | 66.6M | 65.6M | 64.8M | — | — |
| Shares Outstanding (Diluted) | 73.4M | 72.6M | 72.2M | — | — |
| Dividends Per Share | $0.33 | $0.31 | $0.29 | — | — |